9th November 2020
- 0 comments
BiVictriX Therapeutics has completed a £1m funding round from existing shareholders including Acceleris Private Investors, the Development Bank of Wales & BioCity Investments, alongside the Future Fund.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.